MedPath

哈尔滨华瑞生化药业有限责任公司

Ownership
-
Established
2000-06-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Acetylcysteine Granules

Product Name
乙酰半胱氨酸颗粒
Approval Number
国药准字H20249277
Approval Date
Nov 5, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20244972
Approval Date
Sep 26, 2024
NMPA

Ibuprofen Granules

Product Name
布洛芬颗粒
Approval Number
国药准字H20247140
Approval Date
Jun 26, 2024
NMPA

回春如意胶囊

Approval Number
国药准字Z23021228
Approval Date
Dec 30, 2023
NMPA

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20234622
Approval Date
Dec 13, 2023
NMPA

Ibuprofen Granules

Product Name
布洛芬颗粒
Approval Number
国药准字H20083901
Approval Date
Aug 19, 2023
NMPA

Metronidazole and Fenbufen Capsules

Product Name
甲硝唑芬布芬胶囊
Approval Number
国药准字H20073996
Approval Date
Jun 3, 2023
NMPA

Pancreatin Enteric-coated Tablets

Product Name
胰酶肠溶片
Approval Number
国药准字H14023738
Approval Date
Nov 24, 2020
NMPA

Compound Gastric Mucin Capsules

Product Name
复方胃膜素胶囊
Approval Number
国药准字H23023363
Approval Date
Apr 20, 2020
NMPA

小儿百乐片

Approval Number
国药准字Z23021234
Approval Date
Apr 20, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.